LBRX insider buying and SEC filings, explained
LB Pharmaceuticals Inc. · CIK 1691082
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 30, 2026 | Other purchase | David Kroin (10% owner) bought 286,205 Pre-Funded Warrants (Right to Buy) at $34.94 ($10.0M), reported as a purchase (code P). Holdings up 76% to 664,649 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Aug 3, 2026 |
| Feb 6, 2026 | Other purchase | David Kroin (10% owner) bought 472,369 Pre-Funded Warrants (Right to Buy) directly and indirectly (by entity) at $21.17 ($10.0M), reported as a purchase (code P). New position of 378,444 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners. | SEC filing Filed Feb 10, 2026 |
11 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow LBRX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.